Calidi Biotherapeutics, Inc. (CLDI)
0.6993
+0.02
(+2.99%)
USD |
NYAM |
Nov 06, 10:32
Calidi Biotherapeutics Net Income (Quarterly) : -4.16M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.16M |
| March 31, 2026 | -4.417M |
| December 31, 2025 | -4.059M |
| September 30, 2025 | -10.85M |
| June 30, 2025 | -5.761M |
| March 31, 2025 | -5.062M |
| December 31, 2024 | -4.148M |
| September 30, 2024 | -5.069M |
| June 30, 2024 | -5.767M |
| March 31, 2024 | -7.225M |
| December 31, 2023 | -8.229M |
| Date | Value |
|---|---|
| September 30, 2023 | -2.024M |
| June 30, 2023 | -12.50M |
| March 31, 2023 | -6.462M |
| December 31, 2022 | -7.756M |
| September 30, 2022 | -5.355M |
| June 30, 2022 | 4.161M |
| March 31, 2022 | 1.462M |
| December 31, 2021 | 4.293M |
| September 30, 2021 | -0.8233M |
| June 30, 2021 | -0.01M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.16M |
| EPS Diluted (Quarterly) | -2.938 |
| Enterprise Value | -0.9339M |
| Earnings Yield | -7.73K% |
| Normalized Earnings Yield | -7726.24 |